NewGLAB Pharma CO.,LTD

A214870

KR7214870008

Phones & Handheld Devices

End-of-day quote Korea S.E. Other stock markets 18:00:00 2023-03-08 EST			5-day change	1st Jan Change
1,383 ^KRW	-27.44%		-.--%	-.--%

03-04	NewGLAB Pharma CO.,LTD announced that it has received KRW 6.835 billion in funding from Namhwa Corporation, SLP Co. Ltd. and other investors	CI
02-22	NewGLAB Pharma CO.,LTD announced that it expects to receive KRW 6.835 billion in funding from Namhwa Corporation, SLP Co. Ltd. and other investors	CI

NewGLAB CO.,LTD announced that it has received KRW 9.23 billion in funding

March 21, 2021

On March 22, 2021, NewGLAB CO.,LTD (KOSDAQ:A214870) closed the transaction.

Latest news about NewGLAB Pharma CO.,LTD

NewGLAB Pharma CO.,LTD announced that it has received KRW 6.835 billion in funding from Namhwa Corporation, SLP Co. Ltd. and other investors	03-03	CI
NewGLAB Pharma CO.,LTD announced that it expects to receive KRW 6.835 billion in funding from Namhwa Corporation, SLP Co. Ltd. and other investors	02-21	CI
NewGLAB Pharma CO.,LTD(KOSDAQ:A214870) dropped from S&P Global BMI Index	23-06-19	CI
NewGLAB Pharma CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
NewGLAB Pharma CO.,LTD announced that it has received KRW 25 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm	22-04-04	CI
NewGLAB Pharma CO.,LTD announced that it expects to receive KRW 35 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm	21-11-29	CI
NewGLAB CO.,LTD announced that it has received KRW 9.23 billion in funding	21-03-21	CI
NewGLAB CO.,LTD announced that it expects to receive KRW 9.23 billion in funding	21-03-11	CI
NewGLAB CO.,LTD announced that it has received KRW 35 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm	20-10-19	CI
NewGLAB CO.,LTD announced that it expects to receive KRW 35 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm	20-09-27	CI
NewGLAB CO.,LTD announced that it has received KRW 18 billion in funding	19-11-07	CI
NewGLAB CO.,LTD announced that it expects to receive KRW 18 billion in funding	19-10-15	CI
NewGLAB CO.,LTD(KOSDAQ:A214870) added to S&P Global BMI Index	19-09-23	CI
NewGLAB CO.,LTD announced that it has received KRW 15 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm	19-07-18	CI
An unknown buyer acquired 3.8% stake in NewGLAB CO.,LTD from Ahrenel International.	19-06-03	CI
NewGLAB CO.,LTD announced that it has received KRW 10.000001088 billion in funding	19-04-28	CI
NewGLAB CO.,LTD announced that it has received KRW 5 billion in funding	19-04-11	CI
HDPRO Co., Ltd. announced that it expects to receive KRW 15 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm	18-12-18	CI
Arenel International Co., Ltd. acquired 13.1% stake in HDPRO Co., Ltd. from NextEye Co., Ltd. for KRW 11 billion.	18-12-18	CI
HDPRO Co., Ltd. announced that it expects to receive KRW 10.000001088 billion in funding	18-07-12	CI
HDPRO Co., Ltd. announced that it has received KRW 32.4999952 billion in funding	18-01-23	CI
HDPRO Co., Ltd. announced that it expects to receive KRW 5 billion in funding	17-12-28	CI
C&KY Holdings Co., Ltd. completed the acquisition of 14.14% stake in HDPRO Co., Ltd. from KODI CO., LTD.	17-10-29	CI
HDPRO Co., Ltd. announced that it has received KRW 10 billion in funding	17-10-23	CI
TS Holdings Co., Ltd. and 2 other shareholders completed the acquisition of 5.34% stake in HDPRO Co., Ltd. from C&KY Holdings Co., Ltd.	17-10-22	CI

NewGLab Pharma Co Ltd, formerly NewGLab Co Ltd, is a company mainly engaged in the manufacturing and sale of closed-circuit television (CCTV) cameras. The Company's product portfolio consists of general analog cameras that used for CCTVs, high definition (HD) analog cameras, HD-serial digital interface (SDI) cameras, extend (EX)-SDI cameras, internet protocol (IP) cameras that used for network CCTVs, digital video recorders (DVRs) that used for image storage devices, network video recorders (NVRs) and others. In addition, the Company is involved in the business of 5G smartphone distribution. The Company distributes its products within domestic market and to overseas markets.

Sector

Phones & Handheld Devices

Calendar

2024-08-12 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Phones & Handheld Devices

	1st Jan change	Capi.
NEWGLAB PHARMA CO.,LTD	-.--%	47.83M
SHENZHEN AISIDI CO., LTD.	+18.84%	1.89B
HTC CORPORATION	-15.79%	1.12B
MERRY ELECTRONICS CO., LTD.	+12.33%	842M
JNTC CO., LTD.	+53.66%	779M
SK NETWORKS COMPANY LIMITED	-11.83%	773M
SHELLY GROUP AD	+54.99%	732M
NINGBO BIRD CO.,LTD.	-28.07%	368M
OPTIEMUS INFRACOM LIMITED $Stock Optiemus Infracom Limited$	-8.67%	288M
UIL CO., LTD.	+26.57%	106M

Other Phones & Handheld Devices

NewGLAB Pharma CO.,LTD

Equities

A214870

KR7214870008

Phones & Handheld Devices

NewGLAB CO.,LTD announced that it has received KRW 9.23 billion in funding

Latest news about NewGLAB Pharma CO.,LTD

Chart NewGLAB Pharma CO.,LTD

Company Profile

Income Statement Evolution

Sector Other Phones & Handheld Devices